Positioning of advanced therapies in patients with moderate-to-severe Crohn's disease
{{output}}
The treatment landscape for Crohn's disease (CD) has evolved substantially in the 21st century with the advent of advanced therapies. Since the introduction of tumour necrosis factor (TNF) antagonists, new classes of advanced CD therapies have been approved f... ...
